Form EFFECT NLS Pharmaceutics Ltd.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | September 9, 2025 4:00 P.M. |
| Form: | F-4 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- US Expats With Foreign Companies Face New International Tax Rules From 2026
- Northmin Reports Highest Grade Copper and Silver Results Received to Date from Its Tynagh Drill Program
- IDEAYA Biosciences Announces the Promotion of Dr. Michael White to President, Research and Development
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
